Home > Balance Sheet > BALAXI PHARMACEUTICALS

BALAXI PHARMACEUTICALS
Balance Sheet

BALAXI PHARMACEUTICALS is part of below Screeners ↓
Top Small Cap Stocks with Best Fundamentals
Best 1M Momentum Small Cap Stocks
COMMUNITY POLL
for BALAXI PHARMACEUTICALS
Please provide your vote to see the results

BALAXI PHARMACEUTICALS Last 5 Year Balance Sheet History

[Consolidated]

Mar2023Mar2022Mar2021Mar2020Mar2019
EQUITY AND LIABILITIES
Share Capital ₹10 Cr₹10.00 Cr₹10.00 Cr₹10.00 Cr₹3.04 Cr
    Equity - Authorised ₹40 Cr₹40 Cr₹40 Cr₹40 Cr₹40 Cr
    Equity - Issued ₹10 Cr₹10.00 Cr₹10.00 Cr₹10.00 Cr₹3.04 Cr
    Equity Paid Up ₹10 Cr₹10.00 Cr₹10.00 Cr₹10.00 Cr₹3.04 Cr
    Equity Shares Forfeited -----
    Adjustments to Equity -----
    Preference Capital Paid Up -----
    Face Value ₹10.00₹10.00₹10.00₹10.00₹10.00
Share Warrants & Outstandings ₹10 Cr----
Total Reserves ₹162 Cr₹103 Cr₹55 Cr₹18 Cr₹0.48 Cr
    Securities Premium ₹19 Cr₹11 Cr₹11 Cr₹11 Cr₹0.12 Cr
    Capital Reserves -----
    Profit & Loss Account Balance ₹143 Cr₹92 Cr₹44 Cr₹6.45 Cr₹0.32 Cr
    General Reserves ₹0.05 Cr₹0.05 Cr₹0.05 Cr₹0.05 Cr₹0.02 Cr
    Other Reserves ----₹0.03 Cr
Reserve excluding Revaluation Reserve ₹162 Cr₹103 Cr₹55 Cr₹18 Cr₹0.48 Cr
Revaluation reserve -----
Shareholder's Funds ₹183 Cr₹113 Cr₹65 Cr₹28 Cr₹3.52 Cr
Minority Interest -----
Long-Term Borrowings -----
Secured Loans -----
    Non Convertible Debentures -----
    Converible Debentures & Bonds -----
    Packing Credit - Bank -----
    Inter Corporate & Security Deposit -----
    Term Loans - Banks -----
    Term Loans - Institutions -----
    Other Secured -----
Unsecured Loans ₹0.87 Cr----
    Fixed Deposits - Public -----
    Loans and advances from subsidiaries -----
    Inter Corporate Deposits (Unsecured) -----
    Foreign Currency Convertible Notes -----
    Long Term Loan in Foreign Currency -----
    Loans - Banks -----
    Loans - Govt. -----
    Loans - Others -----
    Other Unsecured Loan ₹0.87 Cr----
Deferred Tax Assets / Liabilities ₹1.10 Cr₹0.04 Cr₹0.01 Cr₹0.00 Cr-
    Deferred Tax Assets -----
    Deferred Tax Liability ₹1.10 Cr₹0.04 Cr₹0.01 Cr₹0.00 Cr-
Other Long Term Liabilities ₹1.69 Cr----
Long Term Trade Payables -----
Long Term Provisions -----
Total Non-Current Liabilities ₹3.66 Cr₹0.04 Cr₹0.01 Cr₹0.00 Cr-
Current Liabilities -----
Trade Payables ₹35 Cr₹49 Cr₹25 Cr₹4.85 Cr₹2.08 Cr
    Sundry Creditors ₹35 Cr₹49 Cr₹25 Cr₹4.85 Cr₹2.08 Cr
    Acceptances -----
    Due to Subsidiaries- Trade Payables -----
Other Current Liabilities ₹2.81 Cr₹3.26 Cr₹0.14 Cr₹0.96 Cr₹0.04 Cr
    Bank Overdraft / Short term credit -----
    Advances received from customers -----
    Interest Accrued But Not Due -----
    Share Application Money -----
    Current maturity of Debentures & Bonds -----
    Current maturity - Others -----
    Other Liabilities ₹2.81 Cr₹3.26 Cr₹0.14 Cr₹0.96 Cr₹0.04 Cr
Short Term Borrowings ₹11 Cr₹3.64 Cr₹3.66 Cr--
    Secured ST Loans repayable on Demands ₹4.99 Cr₹2.64 Cr₹0.33 Cr--
    Working Capital Loans- Sec ₹4.42 Cr----
    Buyers Credits - Unsec -----
    Commercial Borrowings- Unsec -----
    Other Unsecured Loans ₹1.34 Cr₹1.00 Cr₹3.33 Cr--
Short Term Provisions ₹5.06 Cr₹7.25 Cr₹6.01 Cr₹2.42 Cr₹0.47 Cr
    Proposed Equity Dividend -----
    Provision for Corporate Dividend Tax -----
    Provision for Tax ₹5.06 Cr₹7.25 Cr₹6.01 Cr₹2.42 Cr₹0.47 Cr
    Provision for post retirement benefits -----
    Preference Dividend -----
    Other Provisions -----
Total Current Liabilities ₹53 Cr₹63 Cr₹35 Cr₹8.22 Cr₹2.59 Cr
Total Liabilities ₹240 Cr₹176 Cr₹100 Cr₹36 Cr₹6.11 Cr
ASSETS
Gross Block ₹44 Cr₹30 Cr₹2.75 Cr₹0.19 Cr₹0.01 Cr
Less: Accumulated Depreciation ₹2.35 Cr₹0.76 Cr₹0.30 Cr--
Less: Impairment of Assets -----
Net Block ₹41 Cr₹29 Cr₹2.45 Cr₹0.19 Cr₹0.01 Cr
Lease Adjustment A/c -----
Capital Work in Progress ₹2.83 Cr₹0.57 Cr---
Non Current Investments --₹3.42 Cr--
Long Term Investment --₹3.42 Cr--
    Quoted -----
    Unquoted --₹3.42 Cr--
Long Term Loans & Advances ₹1.52 Cr₹1.27 Cr₹0.05 Cr₹0.92 Cr₹0.32 Cr
Other Non Current Assets ₹0.40 Cr₹4.87 Cr---
Total Non-Current Assets ₹46 Cr₹35 Cr₹5.91 Cr₹1.11 Cr₹0.33 Cr
Current Assets Loans & Advances -----
Currents Investments -----
    Quoted -----
    Unquoted -----
Inventories ₹105 Cr₹99 Cr₹14 Cr₹0.83 Cr-
    Raw Materials -----
    Work-in Progress -----
    Finished Goods -----
    Packing Materials -----
    Stores Ā and Spare -----
    Other Inventory ₹105 Cr₹99 Cr₹14 Cr₹0.83 Cr-
Sundry Debtors ₹52 Cr₹28 Cr₹77 Cr₹30 Cr₹5.47 Cr
    Debtors more than Six months ₹12 Cr₹13 Cr---
    Debtors Others ₹40 Cr₹15 Cr₹77 Cr₹30 Cr₹5.47 Cr
Cash and Bank ₹28 Cr₹7.19 Cr₹1.67 Cr₹4.00 Cr₹0.13 Cr
    Cash in hand -₹0.62 Cr₹0.05 Cr₹0.01 Cr₹0.01 Cr
    Balances at Bank ₹28 Cr₹6.57 Cr₹1.62 Cr₹3.99 Cr₹0.13 Cr
    Other cash and bank balances -----
Other Current Assets ₹4.52 Cr₹3.90 Cr₹0.77 Cr--
    Interest accrued on Investments -----
    Interest accrued on Debentures -----
    Deposits with Government -----
    Interest accrued and or due on loans -----
    Prepaid Expenses ₹3.78 Cr₹3.12 Cr₹0.72 Cr--
    Other current_assets ₹0.74 Cr₹0.78 Cr₹0.05 Cr--
Short Term Loans and Advances ₹3.47 Cr₹3.65 Cr₹0.95 Cr₹0.31 Cr₹0.17 Cr
    Advances recoverable in cash or in kind ₹2.15 Cr₹2.37 Cr₹0.35 Cr₹0.31 Cr₹0.17 Cr
    Advance income tax and TDS ₹0.67 Cr₹0.78 Cr₹0.61 Cr--
    Amounts due from directors -----
    Due From Subsidiaries -----
    Inter corporate deposits -----
    Corporate Deposits -----
    Other Loans & Advances ₹0.65 Cr₹0.50 Cr---
Total Current Assets ₹194 Cr₹141 Cr₹94 Cr₹35 Cr₹5.78 Cr
Net Current Assets (Including Current Investments) ₹140 Cr₹78 Cr₹59 Cr₹27 Cr₹3.19 Cr
Miscellaneous Expenses not written off -----
Total Assets ₹240 Cr₹176 Cr₹100 Cr₹36 Cr₹6.11 Cr
Contingent Liabilities -----
Total Debt ₹12 Cr₹3.64 Cr₹3.66 Cr--
Book Value -113.1664.9827.7511.58
Adjusted Book Value 169.51113.1664.9827.7511.58

Compare Balance Sheet of peers of BALAXI PHARMACEUTICALS

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
BALAXI PHARMACEUTICALS ₹643.5 Cr 2.2% 15% 7.1% Stock Analytics
ADANI ENTERPRISES ₹351,109.0 Cr 0.5% -0.8% 72.9% Stock Analytics
REDINGTON ₹17,402.3 Cr 2.2% 8.4% 31.6% Stock Analytics
HONASA CONSUMER ₹13,911.7 Cr 6.1% 16% NA Stock Analytics
MMTC ₹11,448.0 Cr 5.3% 14.8% 155.7% Stock Analytics
MSTC ₹6,407.1 Cr 4.7% 6.3% 242.8% Stock Analytics


BALAXI PHARMACEUTICALS Share Price vs Sensex

Share Price Returns(%) 1 Week 1 Month 1 Year
BALAXI PHARMACEUTICALS

2.2%

15%

7.1%

SENSEX

0.9%

1.5%

23.6%


You may also like the below Video Courses